Royal Bank of Canada
RPTP

Royal Bank of Canada’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Royal Bank of Canada’s Portfolio RPTP Stock Details RPTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-65
Closed – – 7133
2015
Q4 		$0 Buy
65
+25
+63% +$145 ﹤0.01% 7272
2015
Q3 		$0 Buy
+40
New +$490 ﹤0.01% 7098
2015
Q2 		– Sell
-7
Closed – – 6981
2015
Q1 		$0 Sell
7
-2,985,845
-100% -$30.5M ﹤0.01% 6801
2014
Q4 		$31.4M Sell
2,985,852
-36,338
-1% -$355K 0.02% 625
2014
Q3 		$29M Sell
3,022,190
-7,333
-0.2% -$74.9K 0.02% 615
2014
Q2 		$35M Buy
3,029,523
+57,900
+2% +$527K 0.02% 508
2014
Q1 		$29.7M Buy
2,971,623
+7
+0% +$101 0.02% 547
2013
Q4 		$38.7M Hold
2,971,616
– – 0.03% 463
2013
Q3 		$44.3M Buy
+2,971,616
New +$35.6M 0.03% 391

Other funds holding RPTP

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Royal Bank of Canada's RPTP Position: Q1 2016 in Review

Royal Bank of Canada sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q1 2016, closing a stake of 65 shares.

Royal Bank of Canada first reported a position in RPTP in Q3 2013 and held it in 9 quarters. The position peaked at $44.3M in Q3 2013. 97 funds tracked by Wall St. Rank hold RPTP as of Q1 2016.

  • Royal Bank of Canada reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q1 2016 after selling out during the quarter.
  • Royal Bank of Canada sold 65 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q1 2016.
  • Royal Bank of Canada first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q3 2013 and held it in 9 quarters.
  • Royal Bank of Canada's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $44.3M in Q3 2013.
  • 97 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q1 2016.

Based on Royal Bank of Canada's 13F filing for Q1 2016, filed 16 May 2016.